Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood
Completed
- Conditions
- Clotting Disorders
- Registration Number
- NCT01375725
- Lead Sponsor
- Universal Biosensors Pty Ltd
- Brief Summary
The purpose of this study is to measure prothrombin time (PT) expressed in International Normalised Ratio (INR) units in persons receiving coumadin (warfarin) treatment on an experimental device and a commercially available device. This study will involve taking a finger-puncture and testing onto a strip and meter system for the experimental and commercially available devices.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Are currently taking coumadin (warfarin)
- Are aged 18 years or older
- Able and willing to provide informed consent
- Can understand (read and write) English
- Required to provide a capillary sample as part of their routine medical check
Exclusion Criteria
- Previously participated in this study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PT/INR values from the experimental device will be statistically correlated to results obtained from a commercially available device Five days to collect data and up to two weeks to generate correlation graph To determine the correlation of PT/INR values between an experimental and commercial device
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
White River Diagnostic Clinic
🇺🇸Batesville, Arkansas, United States